医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
21期
251-252
,共2页
中心静脉导管%泼尼松%结核性腹膜炎
中心靜脈導管%潑尼鬆%結覈性腹膜炎
중심정맥도관%발니송%결핵성복막염
Central venous catheter%prednisone%tuberculous peritonitis
目的：研究腹腔置入中心静脉导管引流腹水联合泼尼松治疗结核性腹膜炎的临床疗效。方法：将47例伴有大量腹水的结核性腹膜炎患者随机分为两组：治疗组24例，采用中心静脉导管置入腹腔引流腹水并口服泼尼松；对照组23例，采用常规腹腔腔穿刺抽腹水。两组均采用3HRZE/9HRE抗结核治疗方案。结果：治疗组腹水消失时间明显短于对照组，发生肠粘连、肠梗阻小于对照组，差异有统计学意义（P＜0.05），两组副反应无明显差异（P>0.05）。结论：腹腔置管引流联合泼尼松治疗大量腹水的结核性腹膜炎疗效确切，副作用小，值得进一步推广。
目的：研究腹腔置入中心靜脈導管引流腹水聯閤潑尼鬆治療結覈性腹膜炎的臨床療效。方法：將47例伴有大量腹水的結覈性腹膜炎患者隨機分為兩組：治療組24例，採用中心靜脈導管置入腹腔引流腹水併口服潑尼鬆；對照組23例，採用常規腹腔腔穿刺抽腹水。兩組均採用3HRZE/9HRE抗結覈治療方案。結果：治療組腹水消失時間明顯短于對照組，髮生腸粘連、腸梗阻小于對照組，差異有統計學意義（P＜0.05），兩組副反應無明顯差異（P>0.05）。結論：腹腔置管引流聯閤潑尼鬆治療大量腹水的結覈性腹膜炎療效確切，副作用小，值得進一步推廣。
목적：연구복강치입중심정맥도관인류복수연합발니송치료결핵성복막염적림상료효。방법：장47례반유대량복수적결핵성복막염환자수궤분위량조：치료조24례，채용중심정맥도관치입복강인류복수병구복발니송；대조조23례，채용상규복강강천자추복수。량조균채용3HRZE/9HRE항결핵치료방안。결과：치료조복수소실시간명현단우대조조，발생장점련、장경조소우대조조，차이유통계학의의（P＜0.05），량조부반응무명현차이（P>0.05）。결론：복강치관인류연합발니송치료대량복수적결핵성복막염료효학절，부작용소，치득진일보추엄。
Objective To observe the effect of central venous catheterition combined with prednisone treat tuberculous peritonitis. Methods 47 tuberculous peritonitis patients were randomly divided into two groups,the treatment group received the treatment of depositing a central venous catheter in abdominal cavity cavity and taking prednisone.group B received the treatment of removing fluid from the cavity with abdominal centesis intermittently.both groups were gived regular anti-tuberculosis therapy of 3HRZE/9HRE. Result The incidenc of ankylenteron and abdomina adhesions is less in the treatment group, and the time of pleural effusion absorption was shorter in treatment group(P<0.05).the incidenc of il effect was no significant diffrence between the two groups(P>0.05). Conclusion It is effective method to treat tuberculous peritonitis by central venous catheter combine prednisone, and il effect little ,worth to further clinical investigation.
